Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
2.750
-0.030 (-1.08%)
At close: Jan 23, 2026, 4:00 PM EST
2.700
-0.050 (-1.82%)
After-hours: Jan 23, 2026, 4:45 PM EST
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $6.46 million as of January 23, 2026. Its market cap has decreased by -58.93% in one year.
Market Cap
6.46M
Enterprise Value
550.51K
1-Year Change
-58.93%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $6.46M, a decrease of -88.72%. That is a compound annual growth rate of -37.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 6.46M | 10.44% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abpro Holdings | 7.08M |
| Theriva Biologics | 7.02M |
| Silexion Therapeutics | 6.78M |
| Genprex | 6.59M |
| Alaunos Therapeutics | 6.54M |
| Purple Biotech | 6.52M |
| Bio Green Med Solution | 6.47M |
| Adial Pharmaceuticals | 6.43M |